Literature DB >> 30572276

Contrasting contributions of anhedonia to obsessive-compulsive, hoarding, and post-traumatic stress disorders.

Helen Pushkarskaya1, Kunmi Sobowale2, Daniel Henick3, David F Tolin4, Alan Anticevic5, Godfrey D Pearlson6, Ifat Levy7, Ilan Harpaz-Rotem8, Christopher Pittenger9.   

Abstract

Anhedonia is a transdiagnostic construct that can occur independent of other symptoms of depression; its role in neuropsychiatric disorders that are not primarily affective, such as obsessive compulsive disorder (OCD), hoarding disorder (HD), and post-traumatic stress disorder (PTSD) has received limited attention. This paper addresses this gap. First, the data revealed a positive contribution of anhedonia, beyond the effects of general depression, to symptom severity in OCD but not in HD or PTSD. Second, anhedonia was operationalized as a reduced sensitivity to rewards, which allowed employing the value based decision making framework to investigate effects of anhedonia on reward-related behavioral outcomes, such as increased risk aversion and increased difficulty of making value-based choices. Both self-report and behavior-based measures were used to characterize individual risk aversion: risk perception and risk-taking propensities (measured using the Domain Specific Risk Taking scale) and risk attitudes evaluated using a gambling task. Data revealed the positive theoretically predicted correlation between anhedonia and risk perception in OCD; effects on self-reported risk taking and behavior-based risk aversion were non-significant. The same relations were weaker in HD and absent in PTSD. Response time during a gambling task, an index of difficulty of making value-based choices, significantly correlated with anhedonia in individuals with OCD and individuals with HD, even after controlling for general depression, but not in individuals with PTSD. The results suggest a unique contribution of one aspect of anhedonia in obsessive-compulsive disorder and confirm the importance of investigating the role of anhedonia transdiagnostically beyond affective and psychotic disorders.
Copyright © 2018. Published by Elsevier Ltd.

Entities:  

Mesh:

Year:  2018        PMID: 30572276     DOI: 10.1016/j.jpsychires.2018.11.029

Source DB:  PubMed          Journal:  J Psychiatr Res        ISSN: 0022-3956            Impact factor:   4.791


  5 in total

1.  Animal models of OCD-relevant processes: an RDoC perspective.

Authors:  Christopher Pittenger; Helen Pushkarskaya; Patricia Gruner
Journal:  J Obsessive Compuls Relat Disord       Date:  2019-04-03       Impact factor: 1.677

2.  White matter microstructure associated with anhedonia among individuals with bipolar disorders and high-risk for bipolar disorders.

Authors:  Alexandre Paim Diaz; Brisa S Fernandes; Antonio Lucio Teixeira; Benson Mwangi; Khader M Hasan; Mon-Ju Wu; Sudhakar Selvaraj; Paulo Suen; Tamires Araujo Zanao; Andre R Brunoni; Marsal Sanches; Jair C Soares
Journal:  J Affect Disord       Date:  2021-12-20       Impact factor: 4.839

Review 3.  Toward a neurocircuit-based taxonomy to guide treatment of obsessive-compulsive disorder.

Authors:  Elizabeth Shephard; Emily R Stern; Odile A van den Heuvel; Daniel L C Costa; Marcelo C Batistuzzo; Priscilla B G Godoy; Antonio C Lopes; Andre R Brunoni; Marcelo Q Hoexter; Roseli G Shavitt; Y C Janardhan Reddy; Christine Lochner; Dan J Stein; H Blair Simpson; Euripedes C Miguel
Journal:  Mol Psychiatry       Date:  2021-01-07       Impact factor: 15.992

4.  Adolescent emotional disorder symptoms and transdiagnostic vulnerabilities as predictors of young adult substance use during the COVID-19 pandemic: mediation by substance-related coping behaviors.

Authors:  Junhan Cho; Mariel S Bello; Nina C Christie; John R Monterosso; Adam M Leventhal
Journal:  Cogn Behav Ther       Date:  2021-03-12

5.  Obsessive-Compulsive Symptoms and Other Symptoms of the At-risk Mental State for Psychosis: A Network Perspective.

Authors:  Hui Lin Ong; Adela-Maria Isvoranu; Frederike Schirmbeck; Philip McGuire; Lucia Valmaggia; Matthew J Kempton; Mark van der Gaag; Anita Riecher-Rössler; Rodrigo A Bressan; Neus Barrantes-Vidal; Barnaby Nelson; G Paul Amminger; Patrick McGorry; Christos Pantelis; Marie-Odile Krebs; Merete Nordentoft; Birte Glenthøj; Stephan Ruhrmann; Gabriele Sachs; Bart P F Rutten; Jim van Os; Lieuwe de Haan; Denny Borsboom
Journal:  Schizophr Bull       Date:  2021-07-08       Impact factor: 9.306

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.